A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine

EBioMedicine

Volumn 17, Issue , 2017, Pages 145-156

  Yang, Yujiao ^a,b   Shan, Chao ^a   Zou, Jing ^a   Muruato, Antonio E ^c,d   Bruno, Diniz Nunes ^a,e   de Almeida Medeiros Daniele, Barbosa ^a,e   Vasconcelos, Pedro F C ^e,h   Rossi, Shannan L ^c,f   Weaver, Scott C ^a,c,d,g   Xie, Xuping ^a   Shi, Pei Yong ^a,d,h  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SOUTHWEST UNIVERSITY   (China)

^c Institute for Human Infections and Immunity   (United States)

^d Institute for Translational Sciences   (United States)

^e INSTITUTO EVANDRO CHAGAS   (Brazil)

^f Center for Biodefense and Emerging Infectious Diseases   (United States)

^g Department of Microbiology & Immunology ^*  (United States)

^h UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

Author keywords

Flavivirus assembly; Flavivirus NS1; Zika virus vaccine

Indexed keywords

INACTIVATED VACCINE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; RESTRICTION ENDONUCLEASE; ZIKA VIRUS VACCINE; COMPLEMENTARY DNA; DNA VACCINE; VIRAL PROTEIN;

AEDES AEGYPTI; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CONTROLLED STUDY; DNA SEQUENCE; ELECTROPORATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PLAQUE ASSAY; PLAQUE PURIFICATION; PRIORITY JOURNAL; REPLICON TRANSIENT TRANSFECTION ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VACCINE PRODUCTION; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS REPLICATION; VIRUS VIRULENCE; WESTERN BLOTTING; ANIMAL; CHLOROCEBUS AETHIOPS; CRICETULUS; GENETICS; HAMSTER; HEK293 CELL LINE; IMMUNOLOGY; MISSENSE MUTATION; VERO CELL LINE; ZIKA VIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; CRICETINAE; CRICETULUS; DNA, COMPLEMENTARY; HEK293 CELLS; HUMANS; MICE; MUTATION, MISSENSE; VACCINES, DNA; VACCINES, INACTIVATED; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; ZIKA VIRUS;

EID: 85011994185     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.02.003     Document Type: Article

References (36)

1. Abbink, P., Larocca, R.A., De La Barrera, R.A., Bricault, C.A., Moseley, E.T., Boyd, M., Kirilova, M., Li, Z., Ng'ang'a, D., Nanayakkara, O., et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353 (2016), 1129–1132.
2. Atieh, T., Baronti, C., de Lamballerie, X., Nougairede, A., Simple reverse genetics systems for Asian and African Zika viruses. Sci. Rep., 6, 2016, 39384.
3. Avirutnan, P., Hauhart, R.E., Somnuke, P., Blom, A.M., Diamond, M.S., Atkinson, J.P., Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187 (2011), 424–433.
4. Brown, W.C., Akey, D.L., Konwerski, J.R., Tarrasch, J.T., Skiniotis, G., Kuhn, R.J., Smith, J.L., Extended surface for membrane association in Zika virus NS1 structure. Nat. Struct. Mol. Biol. 23 (2016), 865–867.
5. Chung, K.M., Liszewski, M.K., Nybakken, G., Davis, A.E., Townsend, R.R., Fremont, D.H., Atkinson, J.P., Diamond, M.S., West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 19111–19116.
6. Dawes, B.E., Smalley, C.A., Tiner, B.L., Beasley, D.W.C., Milligan, G.N., Reece, L.M., Hombach, J., Barrett, A.D.T., Research and development of Zika virus vaccines. Npj Vaccines, 1, 2016, 16007.
7. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
8. Dowd, K.A., Ko, S.Y., Morabito, K.M., Yang, E.S., Pelc, R.S., DeMaso, C.R., Castilho, L.R., Abbink, P., Boyd, M., Nityanandam, R., et al. Rapid development of a DNA vaccine for Zika virus. Science 354 (2016), 237–240.
9. Griffiths, E., Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals. World Health Organization Technical Report, vol. 747, 1987.
10. Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., Surasombatpattana, P., Talignani, L., Thomas, F., et al. Biology of zika virus infection in human skin cells. J. Virol. 89 (2015), 8880–8896.
11. Heang, V., Yasuda, C.Y., Sovann, L., Haddow, A.D., Travassos da Rosa, A.P., Tesh, R.B., Kasper, M.R., Zika virus infection, Cambodia, 2010. Emerg. Infect. Dis. 18 (2012), 349–351.
12. Kostyuchenko, V.A., Lim, E.X., Zhang, S., Fibriansah, G., Ng, T.S., Ooi, J.S., Shi, J., Lok, S.M., Structure of the thermally stable Zika virus. Nature 533 (2016), 425–428.
13. Kummerer, B.M., Rice, C.M., Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J. Virol. 76 (2002), 4773–4784.
14. Lanciotti, R.S., Lambert, A.J., Holodniy, M., Saavedra, S., Signor Ldel, C., Phylogeny of zika virus in western hemisphere, 2015. Emerg. Infect. Dis. 22 (2016), 933–935.
15. Larocca, R.A., Abbink, P., Peron, J.P., Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., Boyd, M., Ng'ang'a, D., Kirilova, M., Nityanandam, R., et al. Vaccine protection against Zika virus from Brazil. Nature 536 (2016), 474–478.
16. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A mouse model of zika virus pathogenesis. Cell Host Microbe 19 (2016), 720–730.
17. Leung, J.Y., Pijlman, G.P., Kondratieva, N., Hyde, J., Mackenzie, J.M., Khromykh, A.A., Role of nonstructural protein NS2A in flavivirus assembly. J. Virol. 82 (2008), 4731–4741.
18. Leventis, P.A., Grinstein, S., The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 39 (2010), 407–427.
19. Lindenbach, B.D., Rice, C.M., trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71 (1997), 9608–9617.
20. Lindenbach, B.D., Rice, C.M., Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J. Virol. 73 (1999), 4611–4621.
21. Lindenbach, B.D., Murray, C.L., Thiel, H.J., Rice, C.M., Flaviviridae. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, sixth ed., vol. 1, 2013, Lippincott William & Wilkins, Philadelphia, 712–746.
22. Perera-Lecoin, M., Meertens, L., Carnec, X., Amara, A., Flavivirus entry receptors: an update. Viruses 6 (2014), 69–88.
23. Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N. Engl. J. Med. 374 (2016), 1552–1563.
24. Rossi, S.L., Tesh, R.B., Azar, S.R., Muruato, A.E., Hanley, K.A., Auguste, A.J., Langsjoen, R.M., Paessler, S., Vasilakis, N., Weaver, S.C., Characterization of a novel murine model to study zika virus. Am.J.Trop. Med. Hyg. 94 (2016), 1362–1369.
25. Scaturro, P., Cortese, M., Chatel-Chaix, L., Fischl, W., Bartenschlager, R., Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog., 11, 2015, e1005277.
26. Schuler-Faccini, L., Ribeiro, E.M., Feitosa, I.M.L., Horovitz, D.D.G., Cavalcanti, D.P., Pessoa, A., Doriqui, M.J.R., Neri, J.I., Neto, J.M.D., Wanderley, H.Y.C., et al. Possible association between zika virus infection and microcephaly – Brazil, 2015. Morb. Mortal. Wkly Rep. 65 (2016), 59–62.
27. Schwarz, M.C., Sourisseau, M., Espino, M.M., Gray, E.S., Chambers, M.T., Tortorella, D., Evans, M.J., Rescue of the 1947 zika virus prototype strain with a cytomegalovirus promoter-driven cdna clone. mSphere, 2016, 1.
28. Shan, C., Xie, X., Barrett, A.D., Garcia-Blanco, M.A., Tesh, R.B., Vasconcelos, P.F., Vasilakis, N., Weaver, S.C., Shi, P.Y., Zika virus: diagnosis, therapeutics, and vaccine. ACS Infect. Dis. 2 (2016), 170–172.
29. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An infectious cDNA clone of zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19 (2016), 891–900.
30. Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., Kuhn, R.J., The 3.8 A resolution cryo-EM structure of Zika virus. Science 352 (2016), 467–470.
31. Tsetsarkin, K.A., Kenney, H., Chen, R., Liu, G., Manukyan, H., Whitehead, S.S., Laassri, M., Chumakov, K., Pletnev, A.G., A full-length infectious cDNA clone of zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development. MBio, 7, 2016.
32. Weger-Lucarelli, J., Duggal, N.K., Bullard-Feibelman, K., Veselinovic, M., Romo, H., Nguyen, C., Ruckert, C., Brault, A.C., Bowen, R.A., Stenglein, M., et al. Development and characterization of recombinant virus generated from a new world zika virus infectious clone. J. Virol., 2017, 91.
33. Xie, X., Gayen, S., Kang, C., Yuan, Z., Shi, P.Y., Membrane topology and function of dengue virus NS2A protein. J. Virol. 87 (2013), 4609–4622.
34. Xie, X., Zou, J., Shan, C., Yang, Y., Kum, D.B., Dallmeier, K., Neyts, J., Shi, P.Y., Zika virus replicons for drug discovery. EBioMedicine 12 (2016), 156–160.
35. Youn, S., Li, T., McCune, B.T., Edeling, M.A., Fremont, D.H., Cristea, I.M., Diamond, M.S., Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J. Virol. 86 (2012), 7360–7371.
36. Zou, J., Xie, X., Lee le, T., Chandrasekaran, R., Reynaud, A., Yap, L., Wang, Q.Y., Dong, H., Kang, C., Yuan, Z., et al. Dimerization of flavivirus NS4B protein. J. Virol. 88 (2014), 3379–3391.